Sahar Eldirdiri
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 13
- Infection Control in Healthcare 2
- Tuberculosis Research and Epidemiology 1
- Antimicrobial Resistance in Staphylococcus 1
-
- COVID-19 epidemiological studies 3
Sahar Eldirdiri
16 papers receiving 3.3k citations
Sahar Eldirdiri's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 3k
- Modeling and Simulation 198
- Neurology 46
- Genetics 89
- Molecular Biology 151
Countries citing papers authored by Sahar Eldirdiri
This map shows the geographic impact of Sahar Eldirdiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahar Eldirdiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahar Eldirdiri more than expected).
Fields of papers citing papers by Sahar Eldirdiri
This network shows the impact of papers produced by Sahar Eldirdiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahar Eldirdiri. The network helps show where Sahar Eldirdiri may publish in the future.
Co-authors
The 2 scholars most cited alongside Sahar Eldirdiri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | 2020 | 756 | |
| 3 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 4 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 5 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 6 | 2021 | 228 | |
| 7 | 2021 | 72 | |
| 8 | 2022 | 45 | |
| 9 | 2022 | 31 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2017 | 3 | |
| 15 | 2020 | 1 | |
| 16 | 2023 | 1 |
About Sahar Eldirdiri
Sahar Eldirdiri is a scholar working on Infectious Diseases, Modeling and Simulation, Public Health, Environmental and Occupational Health, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 16 papers that have together received 3.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 epidemiological studies (3 papers), Infection Control in Healthcare (2 papers), Streptococcal Infections and Treatments (1 paper), Tuberculosis Research and Epidemiology (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Infectious Diseases (3k citations), Modeling and Simulation (198 citations), Neurology (46 citations), Genetics (89 citations) and Molecular Biology (151 citations). Sahar Eldirdiri has collaborated with scholars based in United Kingdom. Frequent co-authors include G. Phillips and Jean C. Lee. Their work appears in journals such as Nature, Nature Communications, Journal of Hospital Infection, Scientific Reports and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.